Underlying etiologies of prolonged icterus in neonates

N Najati1, M M Gharebaghi, F Mortazavi

  • 1Department of Pediatrics, Tabriz University of Medical Sciences, Children Hospital, Tabriz, Iran.

Insights

Prolonged neonatal jaundice, persisting beyond 14 days, was studied in 100 newborns. Breastfeeding was identified as the most common cause, highlighting the need for timely diagnosis and management of neonatal jaundice.

Area of Science:

  • Neonatology
  • Pediatric Gastroenterology
  • Clinical Pediatrics

Background:

  • Neonatal jaundice (icterus) is a common condition in newborns.
  • Prolonged neonatal jaundice, lasting over 14 days, requires thorough investigation to prevent severe complications.
  • Identifying the etiology of prolonged jaundice is critical for effective management.

Purpose of the Study:

  • To investigate and determine the underlying causes of prolonged neonatal jaundice.
  • To establish the prevalence of different etiologies contributing to persistent neonatal hyperbilirubinemia.
  • To inform clinical practice regarding the diagnosis and management of prolonged neonatal jaundice.

Main Methods:

  • A prospective study was conducted over six months at Tabriz Children Teaching Hospital.
  • One hundred newborns diagnosed with prolonged icterus were evaluated.
  • Data collected included medical history, physical examination, and laboratory/paraclinical investigations to document the cause of jaundice.

Main Results:

  • Breastfeeding-associated jaundice was the most frequent cause, identified in 75% of cases.
  • Urinary tract infection and glucose-6-phosphate dehydrogenase (G6PD) deficiency each accounted for 7% of cases.
  • Hypothyroidism was found in 4%, with ABO incompatibility, sepsis, and Down syndrome identified in a small number of patients. Etiology remained unknown in 4%.

Conclusions:

  • The underlying causes of prolonged neonatal jaundice can be identified in most cases.
  • Breastfeeding is the predominant cause of prolonged jaundice in the studied population.
  • Prompt etiological diagnosis is essential for appropriate management and prevention of adverse outcomes in neonates with prolonged jaundice.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...